A
Actinium Pharmaceuticals Inc
AMEX:ATNM
Actinium Pharmaceuticals Inc
AMEX:ATNM
Price:
1.16
USD
-1.69%
Market Closed
Market Cap:
$36.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Actinium Pharmaceuticals Inc
AMEX:ATNM
|
US |
|
Fair Isaac Corp
NYSE:FICO
|
US |
|
Fonix Mobile PLC
LSE:FNX
|
UK |
|
Central Japan Railway Co
TSE:9022
|
JP |
|
Archrock Inc
NYSE:AROC
|
US |
|
Compass Group PLC
LSE:CPG
|
UK |
|
Lime Technologies AB (publ)
STO:LIME
|
SE |
|
Jacquet Metals SA
PAR:JCQ
|
FR |
|
Hanover Insurance Group Inc
NYSE:THG
|
US |
|
ARN Media Ltd
ASX:A1N
|
AU |
|
MainStreet Bancshares Inc
NASDAQ:MNSB
|
US |
|
Adapthealth Corp
NASDAQ:AHCO
|
US |
Wall St Price Targets
ATNM Price Targets Summary
Actinium Pharmaceuticals Inc
Actinium Pharmaceuticals Inc
Wall Street analysts forecast ATNM stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for ATNM is 5.1 USD with a low forecast of 2.02 USD and a high forecast of 9.45 USD.
Lowest Forecast
Price Target
2.02
USD
74% Upside
Average Forecast
Price Target
5.1
USD
340% Upside
Highest Forecast
Price Target
9.45
USD
715% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ATNM's stock price target?
Price Target
5.1
USD
5.1
USD
According to Wall Street analysts, the average 1-year price target for ATNM is 5.1 USD with a low forecast of 2.02 USD and a high forecast of 9.45 USD.
What is the Revenue forecast for Actinium Pharmaceuticals Inc?
Projected CAGR
196%
196%
The compound annual growth rate for Revenue over the next 8 years is 196%.
